{"symbol":"ABBV","fiscalQuarter":"Q1-2018","reportDate":"2018-04-26","reportTime":"BMO","status":"reported","company":{"name":"AbbVie Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABBV/earnings/Q1-2018","postBrief":{"headline":"AbbVie Beats on EPS, Stock Up 6.06%","keyNumbers":[{"metric":"EPS","actual":"$1.87","expected":"N/A","surprise":"+4.07%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based solely on numerical results."},"guidanceChanges":{"summary":"No guidance data is available.","changes":[]},"whatItMeans":"AbbVie reported an EPS of $1.87, exceeding expectations, which contributed to a positive stock reaction, with shares rising by 6.06%. However, there was no revenue data provided or guidance updates, leaving some uncertainty about future performance. Investors may view the EPS beat as a sign of underlying strength in the company's operations.","metaDescription":"AbbVie Inc. (ABBV) Q1 2018 earnings: EPS beat by 4.07%. Stock up 6.06%. Full breakdown."}}